Correlation of patient-reported routine assessment of patient index data with clinical measures of disease activity in psoriatic arthritis.
A treat-to-target strategy is recommended for management of psoriatic arthritis (PsA), although...
Read More
Search Physician’s Weekly
Search for articles, editorials, meeting coverage, podcasts, and more
Showing 1 - 20 of 80 results for 'Disease Activity Index for Psoriatic Arthritis'
Measurement of minimal disease activity in psoriatic arthritis using PROMIS-Physical Function or the Health Assessment Questionnaire-Disability Index.
To assess the interchangeability of the Health Assessment Questionnaire-Disability Index (HAQ-DI)...
Read More
Managing Obesity & Fibromyalgia in Psoriatic Disease
During the IFPA 2024, Prof. Philip Mease, MD, from the University of Washington, focused on obesity and fibromyalgia and their impact on psoriatic arthritis.
Read More
CME/CE: PROMs as Important as Disease Activity Indexes for Assessing PsA
This course discusses a study that elucidated the value of patient-reported outcome measures in...
Read MoreAddressing “Unacceptable” Disease Activity in Nearly 60% of Patients With PsA
The majority of patients living with PsA reported experiencing “unacceptable” disease activity, causing potentially serious psychosocial harm, according to survey results collected by researchers with the National Psoriasis...
Read More
Real-World Comparative Effectiveness of Advanced Therapies in Psoriatic Arthritis
PRO-SPIRIT study examines the real-world efficacy results of disease-modifying antirheumatic drugs for patients with psoriatic arthritis.
Read More
PROMs as Important as Disease Activity Indexes for Assessing PsA
New findings show that PROMs were strongly associated with several PsA activity indexes, and are as important as disease activity indexes for assessing PsA.
Read MoreEffectiveness of risankizumab for the treatment of psoriatic arthritis: a multicenter, real-world study.
IL-23 inhibitors were recently approved for the treatment of skin psoriasis and psoriatic arthritis (PsA). Risankizumab, a humanized monoclonal antibody that specifically binds the p19 subunit of IL-23, has proven effective on...
Read More
Cardiovascular Risk Factors in Psoriatic Arthritis
Disease duration and disease activity were significant predictors of cardiovascular risk in PsA patients.
Read MoreAdvertisement
Psoriatic Arthritis: Utilization of BASDAI in Patients with/without Axial Disease
The following is a summary of “Use of the Bath Ankylosing Spondylitis Disease Activity Index...
Read More
Comparing Functional and Resistance Training for Improved Function in Psoriatic Arthritis
The following is a summary of “Effectiveness of functional training versus resistance exercise in...
Read MoreGender Disparities in Patient Characteristics, Safety, and Efficacy of Advanced Therapies in RCT for Psoriatic Arthritis
The following is a summary of “Sex-related differences in patient characteristics, and efficacy and safety of advanced therapies in randomised clinical trials in psoriatic arthritis: a systematic literature review and...
Read More
Diagnostic delay in psoriatic arthritis: insights from a nationwide multicenter study.
This study aimed to investigate the duration of diagnostic delay in patients with psoriatic...
Read More
Brepocitinib Beneficial for Moderate-to-Severe Psoriatic Arthritis
THURSDAY, May 18, 2023 (HealthDay News) — For patients with moderately to severely active...
Read MoreEffect of body mass index on treatment response of biologic-/targeted synthetic-DMARDs in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis. A systematic review.
Overweight and/or obese patients with inflammatory arthritis (IA) have higher disease activity and lower chances of achieving and/or maintaining the treatment targets. Weight/obesity also appears to negatively affect the...
Read More
Gender Disparities in Psoriatic Arthritis Diagnosis: Sonographic and Clinical Variations
The following is a summary of the “Sex-Based Differences in Sonographic and Clinical Findings...
Read More
Effect of Fatigue on Work Productivity and HRQOL in Psoriatic Arthritis
The following is a summary of “Effect of Fatigue on Health-Related Quality of Life and Work...
Read More
Psoriatic Arthritis (PsA): Sex and BMI Potential Impact on Response to Therapy
In the Study of Etanercept and Methotrexate in Combination or as Monotherapy in Subjects with...
Read More
Anti–Tumour Necrosis Factor Therapies’ Efficacy and Drug Survival in Spondyloarthritis Patients
For a study, researchers wanted to assess the long-term efficacy and safety of the first...
Read More
Psychologic Morbidity Among Psoriatic Arthritis
The purpose of this study was to evaluate the effects of biologic medicines and conventional...
Read More